Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bioventus (BVS) Non-Current Debt (2020 - 2026)

Bioventus filings provide 6 years of Non-Current Debt readings, the most recent being $279.0 million for Q4 2025.

  • On a quarterly basis, Non-Current Debt fell 9.52% to $279.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $279.0 million, a 9.52% decrease, with the full-year FY2025 number at $279.0 million, down 9.52% from a year prior.
  • Non-Current Debt hit $279.0 million in Q4 2025 for Bioventus, down from $311.3 million in the prior quarter.
  • In the past five years, Non-Current Debt ranged from a high of $404.3 million in Q2 2023 to a low of $162.4 million in Q4 2021.
  • Median Non-Current Debt over the past 5 years was $344.9 million (2024), compared with a mean of $319.3 million.
  • Biggest five-year swings in Non-Current Debt: soared 142.0% in 2022 and later dropped 16.0% in 2024.
  • Bioventus' Non-Current Debt stood at $339.6 million in 2021, then rose by 13.36% to $385.0 million in 2022, then fell by 4.68% to $367.0 million in 2023, then dropped by 16.0% to $308.3 million in 2024, then dropped by 9.52% to $279.0 million in 2025.
  • The last three reported values for Non-Current Debt were $279.0 million (Q4 2025), $311.3 million (Q3 2025), and $297.9 million (Q2 2025) per Business Quant data.